Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-267
Closed -$34.5K 134
2024
Q1
$34.5K Hold
267
﹤0.01% 131
2023
Q4
$30.5K Hold
267
﹤0.01% 132
2023
Q3
$24.3K Hold
267
﹤0.01% 130
2023
Q2
$30.1K Hold
267
﹤0.01% 127
2023
Q1
$28K Buy
267
+34
+15% +$3.55K ﹤0.01% 133
2022
Q4
$25.8K Buy
233
+9
+4% +$943 ﹤0.01% 129
2022
Q3
$20K Buy
224
+6
+3% +$545 ﹤0.01% 135
2022
Q2
$17K Buy
218
+47
+27% +$3.88K ﹤0.01% 132
2022
Q1
$15K Buy
171
+27
+19% +$2.59K ﹤0.01% 135
2021
Q4
$17K Buy
144
+35
+32% +$4.34K ﹤0.01% 137
2021
Q3
$13K Buy
109
+44
+68% +$5.66K ﹤0.01% 138
2021
Q2
$8K Buy
+65
New +$7.42K ﹤0.01% 140

Other funds holding XYL

Homestead Advisers's XYL Position: Q2 2024 in Review

Homestead Advisers sold out of Xylem (XYL) in Q2 2024, closing a stake of 267 shares — an estimated $34.5K sold.

Homestead Advisers first reported a position in XYL in Q2 2021 and held it in 12 quarters. The position peaked at $34.5K in Q1 2024. 1,033 funds tracked by Wall St. Rank hold XYL as of Q2 2024.

  • Homestead Advisers reported no remaining Xylem position as of Q2 2024 after selling out during the quarter.
  • Homestead Advisers sold 267 Xylem shares in Q2 2024, an estimated $34.5K.
  • Homestead Advisers first reported a position in Xylem in Q2 2021 and held it in 12 quarters.
  • Homestead Advisers's Xylem position peaked at $34.5K in Q1 2024.
  • 1,033 funds tracked by Wall St. Rank held Xylem as of Q2 2024.

Based on Homestead Advisers's 13F filing for Q2 2024, filed 23 Jul 2024.